I came off the Novorapid [short-acting insulin]and theres a kind of instant effect of the weight coming down. (P9, female, diabetes)
Below I break down what this regulatory shift means for Novo Nordisks revenue trajectory, margin profile, and valuation and why it materially strengthens the WeightWatchers thesis as well.
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
Rapid weight loss associated with treatment may also indirectly alter skin barrier function, contributing to dryness or heightened sensitivity
In this review the family is analyzed as well as their cardiovascular and renal effects La enfermedad renal diabtica, frecuente en pacientes con diabetes mellitus tipo 2, se asocia con un marcado incremento de la morbimortalidad, especialmente cardiovascular, y de progresin a enfermedad renal crnica terminal
I confirmed that SMGT-GLP-1 is a great solution for weight loss